statistical analyses – Page 6 – Communicable Diseases Research

Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study

SARS-CoV-2 감염 환자의 사망 위험 요인: 종단 관찰 연구

Observational Study

Published on 2021-04-012022-09-11
Journal: Journal of medical virology [Category] Fulltext, MERS, 바이오마커, 임상,

The Unique Impact of COVID-19 on Human Gut Microbiome Research

Medicine

Published on 2021-03-162022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

Socio‐economic factors do also matter: comments on the article “Can climatic factors explain the differences in COVID-19 incidence and severity across the spanish regions?: an ecological study”

Letter to the Editor

Published on 2021-02-182022-11-01
Journal: Environmental Health [Category] COVID-19, MERS,

Role of complementary Ct chest in patients presenting with acute abdominal symptoms during covid-19 pandemic: a UK experience

COVID-19 대유행 동안 급성 복부 증상을 보이는 환자에서 보완적인 Ct 흉부의 역할: 영국 경험

Article

Published on 2021-01-012022-09-11
Journal: Clinical imaging [Category] SARS, 치료기술,

[키워드] abdomen acquisition Acute abdomen Admission age and gender Analysis association base bases change changes in Chest classic complementary Compliance coronavirus correlation COVID-19 COVID-19 diagnosis CT chest demographics detection rate determine during admission Electronic patient records evaluate general surgery Guidance Information System Intervention lung management p values pathway Patient patient records performed presenting radiology role RT-PCR Screening sensitivity Society specificity statistical analyses statistically significant subsequent surgery surgical surgical intervention Swab Symptom System variables was performed were recorded
[DOI] 10.1016/j.clinimag.2020.09.009 PMC 바로가기 [Article Type] Article

Derivation and validation of a prognostic model for predicting in-hospital mortality in patients admitted with COVID-19 in Wuhan, China: the PLANS (platelet lymphocyte age neutrophil sex) model

Research Article

Published on 2020-12-172022-10-28
Journal: BMC Infectious Diseases [Category] COVID-19, MERS, SARS,

[키워드] age approach assist averaged bootstrap clinician Cohort collected competing COVID-19 COVID-19 patient cumulative demonstrated derivation discharged evaluated External external validation fatality female females Final FIVE healthcare hospital hospitalized COVID-19 patient in-hospital mortality incidence independent internal lack lymphocyte Lymphocyte count median age neutrophil neutrophil count overfitting Patient patient population physician PLANS Platelet predict predicted Predictive predictor predictor variable profiles prognostic model reduce resource Result retrospective cohort risk Sex statistical analyses suggested Support were used with COVID-19 Wuhan Wuhan, China
[DOI] 10.1186/s12879-020-05688-y PMC 바로가기 [Article Type] Research Article

[Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan]

[우한 코로나19 중증/중증환자의 D-dimer, 염증 표지자, 사이토카인 이상 및 질병 중증도의 연관성]

Article

Published on 2020-11-142022-09-11
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zaz [Category] SARS, 바이오마커,

[키워드] abnormality age Analysis analyzed ANC anticoagulant therapy association cardiovascular disease Cerebrovascular disease changes in Chi-square chi-square test Chinese Chronic diseases Coagulation collected COVID-19 COVID-19 infection Critical cytokine Cytokines D-dimer D-dimer levels disease severity dysfunction Dyspnea English fatigue help hsCRP hypertension IL-6 IL-8 immune dysfunction IMPROVE Inflammatory indicators inflammatory markers Mann-Whitney U test medical record medical records men Patient patient age patients PCT performed Prevalence Prophylactic prophylactic anticoagulation proportion single center statistical analyses Student t test Symptom T Test the median the patient TNF-α treated Treatment WBC were assessed women Wuhan
[DOI] 10.3760/cma.j.issn.0253-2727.2020.11.008 PMC 바로가기 [Article Type] Article

BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial

COVID-19에 대한 타고난 면역 반응을 개선하기 위해 브라질에서 의료 종사자의 BCG 재접종: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-10-262022-08-13
Journal: Trials [Category] MERS, SARS, 임상,

[키워드] accompany activate acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Admission Antibiotics antiviral immune response approved assigned Autoimmune Autoimmune diseases Bacillus BCG BCG revaccination BCG vaccination bcg vaccine blinded Blinding block blocks both groups Brazil Breastfeeding carried CFU Characteristics Chemotherapy childhood city clinical trial Committee Comorbidities Comorbidity confirmation Contact contact with control group Coronavirus-2 COVID-19 COVID-19 patient COVID-19 severity COVID-19 symptoms COVID-19 test cross-protection determined by diagnosed direct contact disease disease severity Diseases dissemination dose doses Effectiveness element elicited eligibility criteria Fever health worker health workers healthcare providers HIV hospital Hypothesis ICU identification number IgG and IgM IgM and IgG IgM test immunosuppressive IMPROVE in both group incidence incidence of COVID-19 Inclusion inclusion criteria India induce Infection infections information innate immune response investigator Laboratory lateral flow less macrophages medication meet memory monocyte Monocytes Mortality naso-oropharyngeal swab neutrophil Neutrophils NK NK cell number Nurses objective Open-label outcome outcomes pandemic parallel-group participant physiotherapists platform presenting Prevent Primary outcome Primary outcomes professional protocol randomisation randomised randomised controlled trial randomization Randomized receive recruit recruitment reduce Registered registration number researcher researchers respiratory revaccination right arm RT-PCR Sample size SARS-CoV-2 scar sealed Secondary objective Secondary objectives secondary outcome severe acute respiratory syndrome Coronavirus severity solid tumour specimen statistical analyses status steroid Study protocol Symptom symptomatic infection the disease the vaccine Trial Trial registration Tuberculosis two groups vaccination Vaccine virus virus infection virus infections was performed website WHO
[DOI] 10.1186/s13063-020-04822-0 PMC 바로가기 [Article Type] Letter

Exploring Urological Experience in the COVID-19 Outbreak: American Confederation of Urology (CAU) Survey

Original Article

Published on 2020-07-272022-10-29
Journal: International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology [Category] COVID-19, SARS,

[키워드] addressed America Cancer Care Clinical Management Protocol conducted COVID-19 COVID-19 diagnostic testing [Supplementary Concept] COVID-19 outbreak COVID-19 pandemic Cystectomy disease English experience Factor Health healthcare heterogeneity Hospitalization implementation implication indication infected with COVID-19 Inpatient Italian knowledge Latin management management protocol material nephrectomy North America outpatients Patient performed PPE priority protocol protocols question Radical reported response Safe South America Spanish statistical analyses surgical Surgical Procedures, Operative survey urgency Urology Variability website
[DOI] 10.1590/S1677-5538.IBJU.2020.S119 PMC 바로가기 [Article Type] Original Article

Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine

Original Communication

Published on 2020-07-132022-10-29
Journal: Journal of Neurology [Category] Coronavirus, SARS,

Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-06-052022-10-29
Journal: Trials [Category] COVID-19, SARS,

[키워드] 1:1 7-point ordinal scale accelerate activities activity acute respiratory syndrome adaptive addition administration Admission airway Akershus allocation sequence Analysis anticipated approach automatically baseline Biochemistry Biomarker blinded Blinding Blood C-reactive protein cardiac troponin Chloroquine clinical Clinical outcome Clinical practice clinical status clinical symptom collected condition coronavirus coronavirus disease COVID-19 Culture database Department disease dissemination early treatment element Endpoint examined excluded extracorporeal membrane oxygenation Good harmonization hepatic injury history hospital Hospital admission hospitalisation hospitalised hospitalised patient Hospitalized Hydroxychloroquine Hypothesis In-hospital include independent Inpatient intensive care intensive care unit International Conference Intervention intervention arm Invasive mechanical ventilation Laboratory marker Microbiology Mortality nasopharyngeal NEWS2 non-invasive ventilation Norway number Nurse objective open label Oropharyngeal Oropharyngeal sampling outcome oxygen participant Patient patients peptide Placebo polymerase chain polymerase chain reaction positive Practice Pragmatic pragmatic trial primary endpoint profile Prolonged Protein protocol QT interval randomisation randomised randomised controlled randomised controlled trial randomization Randomized Randomized controlled trial recruited recruitment Registered renal requiring supplemental oxygen resource responsible RT-PCR Safe Sample size SARS-CoV-2 SARS-CoV-2 viral load score secondary Seven standard care statistical analyses status Study protocol subjects Surveillance therapy transcriptase Treatment treatment allocation Trial Two-arm university use of hydroxychloroquine Viral load virological clearance viruses vital signs website
[DOI] 10.1186/s13063-020-04420-0 PMC 바로가기 [Article Type] Letter